Abstract
Background: Fetal surgery for spina bifida aperta may lead to significantly better outcomes than postnatal repair, particularly regarding shunt-dependent hydrocephalus, independent ambulation, and voiding functions. The “Management of Myelomeningocele Study” (MOMS) represents the current benchmark, also in terms of eligibility criteria. Case Report: A positive maternal hepatitis B virus (HBV) status is a MOMS exclusion criterion. Here, we report on the first successful active and passive in utero HBV vaccination of a spina bifida fetus carried by a HBV-positive mother undergoing maternal-fetal surgery. The now 2-year-old infant is healthy, HBV negative, and drew maximal benefit from prenatal surgery. Discussion and Conclusion: Taken together, this patient benefitted maximally from fetal surgery for spina bifida, despite meeting an exclusion criterion. Thus, generally speaking, eligibility criteria for fetal surgery can be challenged under certain circumstances for the benefit of the patient.
References
1.
Chen
HL
, Zha
ML
, Cai
JY
, Qin
G
. Maternal viral load and hepatitis B virus mother-to-child transmission risk: A systematic review and meta-analysis
. Hepatol Res
. 2018
Sep
;48
(10
):788
–801
.
[PubMed]
1386-63462.
World Health Organization
. Hepatitis B vaccines: WHO position paper [Internet]. The weekly Epidemiological Record. 2017
. p. 92:369-392. Available from: www.who.int/wer3.
Bundesamt für Gesundheit BAG). Empfehlungen zur Hepatitis-B-lmpfung.
1997
.4.
Mast
EE
, Weinbaum
CM
, Fiore
AE
, Alter
MJ
, Bell
BP
, Finelli
L
, et al. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. CDC -
. MMWR Morb Mortal Wkly Rep
. 2006
;55
RR16
:1
–25
.0149-21955.
Lee
C
, Gong
Y
, Brok
J
, Boxall
EH
, Gluud
C
. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis
. BMJ
. 2006
Feb
;332
(7537
):328
–36
.
[PubMed]
0959-81386.
Song
YM
, Sung
J
, Yang
S
, Choe
YH
, Chang
YS
, Park
WS
. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus
. [Internet]
. Eur J Pediatr
. 2007
Aug
;166
(8
):813
–8
. Available from: http://link.springer.com/10.1007/s00431-006-0327-5
[PubMed]
0340-61997.
Omeñaca
F
, Garcia-Sicilia
J
, Boceta
R
, García-Corbeira
P.
Hepatitis B response of premature infants after primary and booster immunisation with a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus/ haemophilus influenzae type B vaccine. Infect Dis Obstet Gynecol. 2010
;2010.8.
Posuwan
N
, Wanlapakorn
N
, Sa-Nguanmoo
P
, Wasitthankasem
R
, Vichaiwattana
P
, Klinfueng
S
, et al. The Success of a Universal Hepatitis B Immunization Program as Part of Thailand’s EPI after 22 Years’ Implementation
. PLoS One
. 2016
Mar
;11
(3
):e0150499
.
[PubMed]
1932-62039.
Dunkelberg
JC
, Berkley
EM
, Thiel
KW
, Leslie
KK
. Hepatitis B and C in pregnancy: a review and recommendations for care
. J Perinatol
. 2014
Dec
;34
(12
):882
–91
.
[PubMed]
0743-834610.
André
FE
, Zuckerman
AJ
. Review: protective efficacy of hepatitis B vaccines in neonates
. J Med Virol
. 1994
Oct
;44
(2
):144
–51
.
[PubMed]
0146-661511.
Stevens
CE
, Taylor
PE
, Tong
MJ
, Toy
PT
, Vyas
GN
, Nair
PV
, et al. Yeast-Recombinant Hepatitis B Vaccine: Efficacy With Hepatitis B Immune Globulin in Prevention of Perinatal Hepatitis B Virus Transmission
. JAMA J Am Med Assoc.
; 1987
. 12.
Dionne-Odom
J
, Tita
AT
, Silverman
NS
; Society for Maternal-Fetal Medicine (SMFM)
. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission
. Am J Obstet Gynecol
. 2016
Jan
;214
(1
):6
–14
.
[PubMed]
0002-937813.
Kwon
YJ
, Lee
HS
, Park
MJ
, Shim
SG
. Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t) ide-naïve patients with chronic hepatitis B
. Niger J Clin Pract
. 2015
Nov-Dec
;18
(6
):796
–801
.
[PubMed]
1119-307714.
Hyun
MH
, Lee
YS
, Kim
JH
, Je
JH
, Yoo
YJ
, Yeon
JE
, et al. Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus
. [Internet]
. Aliment Pharmacol Ther
. 2017
Jun
;45
(12
):1493
–505
. Available from: http://www.embase.com/search/results?subaction=viewrecordENT:amp:ENDENTfrom=exportENT:amp:ENDENTid=L615654896%0Ahttp://dx.doi.org/10.1111/apt.14068%0Ahttp://library.deakin.edu.au/resserv?sid=EMBASEENT:amp:ENDENTissn=13652036ENT:amp:ENDENTid=doi:10.1111%2Fapt.14068ENT:amp:ENDENTatitle=Systematic+review+with+meta-analysi
[PubMed]
0269-281315.
European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group
. Nucleoside reverse transcriptase inhibitor backbones and pregnancy outcomes
. [Internet]
. AIDS
. 2019
Feb
;33
(2
):295
–304
. [cited 2019 Feb 16] Available from: http://www.ncbi.nlm.nih.gov/pubmed/30562172
[PubMed]
0269-937016.
Meuli
M
, Meuli-Simmen
C
, Hutchins
GM
, Yingling
CD
, Hoffman
KM
, Harrison
MR
, et al. In utero surgery rescues neurological function at birth in sheep with spina bifida
. Nat Med
. 1995
Apr
;1
(4
):342
–7
.
[PubMed]
1078-895617.
Adzick
NS
, Thom
EA
, Spong
CY
, Brock
JW
3rd, Burrows
PK
, Johnson
MP
, et al.; MOMS Investigators
. A randomized trial of prenatal versus postnatal repair of myelomeningocele
. N Engl J Med
. 2011
Mar
;364
(11
):993
–1004
.
[PubMed]
0028-479318.
Möhrlen
U
, Ochsenbein-Kölble
N
, Mazzone
L
, Kraehenmann
F
, Hüsler
M
, Casanova
B
, et al. Benchmarking against the MOMS Trial: Zurich Results of Open Fetal Surgery for Spina Bifida. Fetal Diagn Ther. 2019
;19.
Selzman
AA
, Elder
JS
, Mapstone
TB
. Urologic consequences of myelodysplasia and other congenital abnormalities of the spinal cord
. Urol Clin North Am
. 1993
Aug
;20
(3
):485
–504
.
[PubMed]
0094-0143© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
